Cura Therapeutics
Montréal
About Cura Therapeutics
Cura Therapeutics is actively seeking strategic partnering opportunities and collaborations with pharmaceutical and biotechnology companies to develop and commercialize cancer immunotherapies based on multifunctional fusion proteins. Their immunotherapy can be used alone or in combination with a wide range of targeted therapies or cell-based therapies such as immune checkpoint inhibitors and CART therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $100.0K
- Funding stage: Seed
- Last round: Seed (May 2025)
- Website: curatherapeutics.com
- Phone: 514-866-0009
Industries & Categories
Biotechnology, Collaboration, Health Care, Therapeutics
Canonical: https://fsome.com/organization/cura-therapeutics-19675 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.